Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study

Keywords

GefitinibMedicineExpanded accessOncologyLung cancerInternal medicineCancerEpidermal growth factor receptor

Affiliated Institutions

Related Publications

Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions

Sharon Barr , Stuart Thomson , Elizabeth Buck +10 more

Over 90% of all cancers are carcinomas, malignancies derived from cells of epithelial origin. As carcinomas progress, these tumors may lose epithelial morphology and acquire mes...

2008 Clinical & Experimental Metastasis 199 citations

A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer

Gerlinde Pilkington , Angela Boland , Tamara Brown +3 more

Our aim was to evaluate the clinical effectiveness of chemotherapy treatments currently licensed in Europe and recommended by the National Institute for Health and Care Excellen...

2015 Thorax 116 citations

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

Elizabeth Buck , Alexandra Eyzaguirre , Sharon Barr +7 more

Abstract Overexpression and enhanced activation of the epidermal growth factor receptor (EGFR) is frequently observed in human carcinomas. Inhibitors of EGFR signaling have show...

2007 Molecular Cancer Therapeutics 186 citations

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi , Delvys Rodríguez‐Abreu , Shirish M. Gadgeel +26 more

In patients with previously untreated metastatic nonsquamous NSCLC without EGFR or ALK mutations, the addition of pembrolizumab to standard chemotherapy of pemetrexed and a plat...

2018 New England Journal of Medicine 6245 citations

A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of <i>EGFR</i>

Philipp Sievers , Martin Sill , Daniel Schrimpf +29 more

Abstract Background Malignant astrocytic gliomas in children show a remarkable biological and clinical diversity. Small in-frame insertions or missense mutations in the epiderma...

2020 Neuro-Oncology 112 citations

Publication Info

Year: 2004
Type: article
Volume: 44
Issue: 2
Pages: 221-230
Citations: 197
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

197

OpenAlex

Cite This

APA Style

                            
                                
                                    Pasi A. Jänne, 
                                
                                    Sarada Gurubhagavatula, 
                                
                                    Beow Y. Yeap
                                
                                et al.
                            
                            (2004). 
                            Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study. 
                            Lung Cancer
                            , 44
                            (2)
                            , 221-230.
                            https://doi.org/10.1016/j.lungcan.2003.12.014
                        

Identifiers

DOI: 10.1016/j.lungcan.2003.12.014